{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:36:51Z","timestamp":1791941811551,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171022"],"award-info":[{"award-number":["82171022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371026"],"award-info":[{"award-number":["82371026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtos.2024.07.005","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T06:20:58Z","timestamp":1721456458000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dry eye disease adverse reaction of pharmacological treatment for early-stage breast cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Jiamu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baikai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3066-8020","authenticated-orcid":false,"given":"Hong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2024.07.005_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int Immunopharm"},{"issue":"12","key":"10.1016\/j.jtos.2024.07.005_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12032-022-01804-x","article-title":"Risk factors for breast cancer in women: an update review","volume":"39","author":"Fakhri","year":"2022","journal-title":"Med Oncol"},{"key":"10.1016\/j.jtos.2024.07.005_bib3","first-page":"71","article-title":"10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event","volume":"38","author":"Hannoun-Levi","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.005_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J Clin"},{"issue":"10074","key":"10.1016\/j.jtos.2024.07.005_bib5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.005_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"23","key":"10.1016\/j.jtos.2024.07.005_bib7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMra1407936","volume":"378","author":"Clayton","year":"2018","journal-title":"Dry Eye. N Engl J Med."},{"issue":"10","key":"10.1016\/j.jtos.2024.07.005_bib8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1634\/theoncologist.2017-0672","article-title":"Adjuvant anthracyclines in breast cancer: what is their role?","volume":"23","author":"Shah","year":"2018","journal-title":"Oncol"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.005_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrclinonc.2013.67","article-title":"Taxane benefit in breast cancer--a role for grade and chromosomal stability","volume":"10","author":"A'Hern","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtos.2024.07.005_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","article-title":"Progress in research on paclitaxel and tumor immunotherapy","volume":"24","author":"Zhu","year":"2019","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.005_bib11","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41598-021-81398-y","article-title":"A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer","volume":"11","author":"Chiang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.07.005_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110214","article-title":"The interactions of docetaxel with tumor microenvironment","volume":"119","author":"Gupta","year":"2023","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.jtos.2024.07.005_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/1756-0500-7-785","article-title":"Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report","volume":"7","author":"Wong","year":"2014","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.005_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1167\/iovs.63.1.38","article-title":"Nicotinamide riboside alleviates corneal and somatic hypersensitivity induced by paclitaxel in male rats","volume":"63","author":"Hamity","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.005_bib15","first-page":"111","article-title":"Meibomian gland changes in breast cancer patients treated with docetaxel-partial results","volume":"67","author":"Stoicescu","year":"2023","journal-title":"Rom J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.005_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188678","article-title":"Platinum-based systematic therapy in triple-negative breast cancer","volume":"1877","author":"Zhu","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jtos.2024.07.005_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2020.02.016","article-title":"Evolving concepts in HER2 evaluation in breast cancer: heterogeneity, HER2-low carcinomas and beyond","volume":"72","author":"Marchi\u00f2","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"4785","key":"10.1016\/j.jtos.2024.07.005_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.jtos.2024.07.005_bib19","article-title":"Risk of ocular adverse events with aromatase inhibitors","volume":"S0008\u20134182","author":"Feng","year":"2023","journal-title":"Can J Ophthalmol. Published online"},{"key":"10.1016\/j.jtos.2024.07.005_bib20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1186\/s12885-019-5986-5","article-title":"Lacrimal drainage system stenosis associated with Trastuzumab emtansine (Kadcyla\u00ae, T-DM1) administration: a case report","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.jtos.2024.07.005_bib21","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S1470-2045(19)30328-6","article-title":"Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study","volume":"20","author":"Banerji","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.005_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-007-9788-0","article-title":"Oestrogen producing enzymes and mammary carcinogenesis: a review","volume":"111","author":"Subramanian","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.005_bib23","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JME-15-0310","article-title":"Aromatase expression and regulation in breast and endometrial cancer","volume":"57","author":"Zhao","year":"2016","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"10.1016\/j.jtos.2024.07.005_bib24","first-page":"2259","article-title":"Joint pain with aromatase inhibitors: abnormal frequency of Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Laroche","year":"2007","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jtos.2024.07.005_bib25","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s00262-023-03565-6","article-title":"Chronological interplay, clinical features, and treatments among patients with cancer and primary Sj\u00f6gren\u2019s syndrome","volume":"72","author":"Witkowski Durand Viel","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"9922","key":"10.1016\/j.jtos.2024.07.005_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.005_bib27","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/s41598-018-20273-9","article-title":"Prevalence and Risk Factors of self-reported dry eye in Brazil using a short symptom questionnaire","volume":"8","author":"Castro","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.005_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1442-9071.2012.02865.x","article-title":"Dry eye syndrome in aromatase inhibitor users","volume":"41","author":"Turaka","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.005_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.breast.2015.08.008","article-title":"Dry eyes and AIs: if you don't ask you won't find out","volume":"24","author":"Inglis","year":"2015","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.005_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bjophthalmol-2016-308473","article-title":"Does endogenous serum oestrogen play a role in meibomian gland dysfunction in postmenopausal women with dry eye?","volume":"101","author":"Golebiowski","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.005_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1167\/iovs.15-18158","article-title":"Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women","volume":"57","author":"Ablamowicz","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.005_bib32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1167\/iovs.12-10457","article-title":"The effects of estrogen and androgen on tear secretion and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats","volume":"55","author":"Song","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.005_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bjophthalmol-2012-302705","article-title":"Low levels of 17-\u03b2-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case-control study","volume":"98","author":"Gagliano","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"4\u20135","key":"10.1016\/j.jtos.2024.07.005_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2009.10.011","article-title":"Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines","volume":"118","author":"Masri","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jtos.2024.07.005_bib35","unstructured":"Menopause. Accessed March 11, 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/menopause."},{"issue":"3\u20135","key":"10.1016\/j.jtos.2024.07.005_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jtos.2024.07.005_bib37","article-title":"Molecular mechanisms of endocrine resistance in estrogen-positive breast cancer","volume":"12","author":"Belachew","year":"2021","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.005_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamaoncol.2021.6214","article-title":"Effects of gonadotropin-releasing hormone analogs on ovarian function against chemotherapy-induced gonadotoxic effects in premenopausal women with breast cancer in China: a randomized clinical trial","volume":"8","author":"Zong","year":"2022","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.005_bib39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.005_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:02:57Z","timestamp":1733464977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012424000740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":40,"alternative-id":["S1542012424000740"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2024.07.005","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dry eye disease adverse reaction of pharmacological treatment for early-stage breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2024.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}